CCKBR and hepatocellular carcinoma: Since we previously found that proglumide therapy prevented the development of dysplastic nodules and HCC in CDE-fed mice (20) and because fibrosis is the greatest risk factor for the development of HCC (32), we examined the role of the CCK-BR on hepatic fibrosis using the DDC and CDE diets.